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Abstract
The systematic use of feedback from patients on treatment progress and treatment satisfaction is a promising method to 
increase treatment effectiveness. The extent to which this also applies to the treatment of children with severe psychiatric 
problems is not clear. We conducted a Randomized Controlled Trial (RCT) to study the effect of adding Feedback Informed 
Treatment (FIT) to care as usual in a child psychiatric sample. Quality of Life (QoL) was used as the primary outcome 
measure and symptom severity as the second. Fifty-one therapists from eight Autism Care Teams in a multi-center facility 
for Child and Adolescent Psychiatry (Karakter) participated and were cluster randomized to the FIT condition (n = 4 teams) 
or the Care as Usual (CAU) condition (n = 4 teams). Children aged 6–18 years, mainly with an Autism Spectrum Disorder 
(ASD) and treated in one of the Autism Care Teams were allocated to the FIT condition (n = 86) or the CAU condition 
(n = 80). Results indicated that adding FIT leads to an increased QoL [F (2,165) = 3.16, p = 0.045]. No additional effects 
were observed for symptom severity decrease [F (2,158) = 0.19, p = 0.825]. No interaction with time was found for QoL nor 
symptom severity. Adding FIT in a child psychiatric setting may increase QoL, but does not appear to decrease symptom 
severity as compared with CAU. It is suggested that FIT positively changes parents’ expectations. Results should be replicated 
in other child psychiatric samples and with an extended theoretical model.
Keywords Feedback informed treatment · Randomized controlled trial · Child and adolescent psychiatry · Autism spectrum 
disorder · Quality of Life · Symptom severity
Introduction
The systematic use of patients’ feedback is a promising 
method to increase the effectiveness of treatment [1–7]. 
Feedback provides critical information on treatment pro-
gress. Furthermore, adding feedback about treatment sat-
isfaction may strengthen the therapeutic alliance between 
patient and therapist, which is known to be one of the most 
important contributors to treatment effect [8–12]. Systematic 
feedback stimulates reflection on treatment effects in rela-
tion to the quality of the therapeutic alliance experienced. In 
particular, it reflects the contribution of the therapist as an 
important partner in this alliance. It is in line with current 
discourse regarding the emancipation of the patient’s role 
in healthcare, e.g., a trend towards shared decision-making 
about treatment [13, 14].
Miller and others developed “Feedback Informed Treat-
ment” (FIT): a systematic way to incorporate feedback in 
each treatment session [15]. FIT stimulates a culture of 
feedback within treatment. The therapist inquires about 
the patient’s well-being at the start of every session and the 
patients’ experience of the session at the end of the session. 
The therapist and the patient reflect in a deliberate way on 
this feedback using an immediate visualization of the feed-
back in a graph. Therapist and patient are able to adapt their 
goals, approach, method and frequency based on the feed-
back and the reference data shown in the graph. Together 
they can generate valuable information about their alliance, 
which enables them to become attuned to each other in a 
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more sophisticated way. The addition of systematic feed-
back can be an important instrument in providing children 
with severe problems with all the value of treatment more 
effectively. In this way, the use of patients’ feedback can 
also be an important communication tool in the context of 
personalized care.
The effect of feedback on treatment outcome, in general, 
has been the subject of research for more than two decades. 
Most of the studies that were published reported small–mod-
erate positive effects on different outcome measures [1–7, 
16]. These studies also show several moderating factors for 
the effect of feedback. In general, more enhanced effects 
are seen in patients who are at risk of treatment failure [6, 
17]. Therapist characteristics also moderate the effect of 
feedback, as shown in studies by Lutz et al. [18] and De 
Jong et al. [19]. It is under debate what kind of feedback 
should ideally be given and to whom. It is suggested that 
feedback given to both therapists and patients is more effec-
tive than feedback to therapists alone [2, 6, 19, 20]. It is 
also thought that the effect of feedback is elevated by apply-
ing a formalized structure for using feedback [16] and by a 
clinical decision tool that is based on feedback measures and 
expected treatment response [6, 21, 22]. The research ques-
tions become more specific around the key question: when 
and for whom is feedback effective? [1, 5].
In 2016, the Cochrane Collaboration published a compre-
hensive systematic review of feedback studies in adults [23]. 
At that time, the conclusion was that insufficient evidence 
was available to demonstrate the efficacy of formalized feed-
back in the treatment of common mental health disorders. 
It was suggested that most of the findings in studies were at 
high risk of different types of bias and relatively low qual-
ity with respect to evidence. It was suggested that future 
research should take into account specific groups, such as 
children, also with a clearly defined assessment of symptom 
severity based on standard classification systems and using 
multiple and additional outcome measures, not assessed by 
the therapist involved in the study [1–3, 23].
Previous research on feedback in treatment has mainly 
been conducted in the field of adult healthcare and the care 
for people with relatively mild concerns. The extent to which 
these findings can be replicated for people with more severe 
problems has been questioned, and whether treatment effects 
can last over a longer period. The latter emphasizes the need 
for longitudinal studies [1–3, 17]. Research on this topic in 
more specific areas, such as child mental healthcare, has 
been recommended in recent systematic reviews [1–3].
Research involving the FIT method or other feedback 
systems is rare in children and adolescents. A cluster ran-
domized study showed that young people aged 11–18 
improved faster when clinicians received weekly feedback 
about treatment progress [24]. Another pilot study, admin-
istered by parents, showed that an increase in conversation 
about treatment progress had a positive effect on the child’s 
functioning and the therapeutic relationship [25].
Most of the feedback-related studies have used symptom 
severity as an outcome measure, using checklists such as the 
Outcome Questionnaire 45 (OQ-45) and Symptom Checklist 
90 (SCL-90); See [1, 2] for an overview. In the past decade, 
a paradigm shift has occurred in the criteria used to evaluate 
(positive) health as a treatment outcome. The definition of 
health has been extended to the patients’ experience of their 
health state. This patient-oriented outcome is covered in the 
concept of (health-related) Quality of Life (QoL) [26, 27]. 
However, only a few feedback effect studies have used QoL 
as an outcome measure. A cluster randomized controlled 
trial showed that an intervention structuring the patient–cli-
nician dialog (feedback) to focus on patients’ views posi-
tively influenced QoL in adult patients with schizophrenia 
[28]. In another randomized controlled trial, the quarterly 
routine use of outcome measures did not improve subjective 
outcomes (like QoL) in adult mental health services [29]. 
Kendrik et al. recommended collecting additional outcome 
measures such as the QoL [23].
Given these recommendations and the limited literature 
on the use of FIT in child and adolescent psychiatric set-
tings, we conducted a cluster randomized trial in a large 
sample of patients, aged under 18 years. Our objective in 
this FIT trial was to evaluate whether FIT increased QoL 
and decreased symptom severity compared with children and 
adolescents who did not use FIT in their treatment.
Methods
Trial design
A cluster randomized controlled trial (RCT) was conducted 
between June 2014 and December 2016. This cluster ran-
domized design was used to minimize contamination bias 
within locations and to stimulate therapists in the experi-
mental group to encourage each other to use FIT (see also 
Kendrik 2016 [23]). Clusters were the outpatient Autism 
Care Teams of eight different locations of Karakter, our 
center for child and adolescent psychiatry in the Nether-
lands. These were randomly allocated to the experimental 
condition (4 teams: Almelo, Arnhem, Ede, Tiel) or the con-
trol condition (4 teams: Apeldoorn, Enschede, Nijmegen, 
Zwolle). All teams used the same clinical protocols.
The Medical Ethics Committee for Arnhem–Nijmegen 
issued a positive judgement for this study (NL number 
48681.091.14 METC no. 2014/144). This trial was reg-
istered with the ISRCTN Clinical Trial Registry with 
trial registration number ISRCTN12284149 (https ://doi.
org/10.1186/ISRCT N1228 4149).
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Participants
Patients eligible for participation in the study were recruited 
between June 2014 and June 2015 from all patients referred 
by primary, secondary and tertiary Health Care services 
to one of the eight Autism Care Teams for diagnostics and 
treatment. Eligibility criteria were as follows: (1) aged 
between 6 and 18 years, (2) referred to one of the eight par-
ticipating Autism Care Teams, (3) Dutch speaking, (4) abil-
ity to complete the outcome questionnaires digitally, and (5) 
Informed Consent was given by the parents and the child if 
12 years or older. Patients were excluded if (1) they did not 
receive any treatment after diagnostics; (2) treatment was 
given in another team or by a therapist who was not trained 
in FIT; (3) FIT was used in fewer than three sessions or (4) 
the parents’ response to the repeated outcome assessment 
was less than two. Diagnosis and classification according 
to the Diagnostic and Statistical Manual for mental disor-
ders (DSM-IV) [30] were confirmed by a psychiatrist for all 
children. This was based on a multidisciplinary assessment 
including a psychiatric observation, developmental assess-
ment, parental interview and school questionnaires. Treat-
ment plans were outlined by a multidisciplinary team and 
confirmed by the psychiatrist based on the diagnosis and in 
accordance with treatment protocols. All children were able 
to communicate verbally with their therapist. All children 
who met these criteria and started treatment in one of the 
Autism Care Teams were eligible for participation.
Parents or caregivers of all children, referred to one of the 
eight Autism Care Teams between June 2014 and June 2015, 
were informed by letter and orally about the goal and design 
of this study and were asked to agree to participate by sign-
ing an Informed Consent form. All children aged 12 years 
and older were also asked to give their Informed Consent.
The flow diagram of the study is presented in Fig. 1. A 
total of 525 children were assessed for eligibility. Of those, 
we had to exclude 240 children because they did not meet 
the inclusion criteria. All 285 eligible participants were 
allocated to the Experimental condition (FIT group, n = 174 
participants) or the Control condition (CAU group, n = 111 
participants), depending on the location to which they were 
referred. In the FIT group, we excluded another 26 partici-
pants who did not receive treatment after diagnostics, 12 
participants who received treatment from a non-FIT-trained 
therapist, 45 participants who were asked for feedback fewer 
than three times and 5 participants with no repeated outcome 
measurement. Therefore, 86 patients were included in the 
FIT group for analyses. In the CAU group, 21 participants 
did not receive treatment after diagnostics, and 10 partici-
pants did not have repeated outcome measures. Therefore, 
80 participants were included in the CAU group for analyses. 
Based on patient-focused feedback theories which suggest 
that feedback is more effective when given immediately, 
frequently and systematically, we expected the number of 
sessions with FIT to moderate the effect on treatment [4, 
31]. Therefore, we divided the FIT group into a group with 
3–8 sessions (n = 41) and a group with 9 or more session 
(n = 45).
Therapists
Fifty-one therapists associated with one of the multidis-
ciplinary Autism Care Teams were included in this study, 
including psychiatrists, psychotherapists (Cognitive Behav-
ioral Therapy and System Therapy), psychologists, social 
workers and family workers. No differences were found in 
the multidisciplinary makeup of the teams or the mean age, 
years of experience and gender. Therapists in the experi-
mental FIT group attended a one-day training course in the 
principles and use of FIT by a certified trainer in accordance 
with manual two of the manuals published by the Interna-
tional Center for Clinical Excellence (ICCE) [32].
Nine therapists left the teams during the study because 
of organizational reorganization and were replaced by new 
therapists. Another sixteen new therapists joined the teams. 
In the case of the FIT group, all new therapists were trained 
in half a day. Therapists in the FIT group attended monthly 
team supervision about FIT during the first 12 months and 
twice monthly for another 6 months. This was undertaken 
with a trained supervisor. Two research assistants regularly 
checked if therapists added new FIT data per patient in the 
digital fit-outcomes program.
Interventions
Therapists in the experimental group added the use of feed-
back in their treatment sessions with the children and par-
ents who participated in this study. They were also given 
the option to use it voluntarily with other patients not par-
ticipating in this study. To standardize the use of feedback, 
therapists used FIT as described in manual two of the ICCE 
Manuals on Feedback Informed Treatment [32] and the 
additional web-based program fit-outcomes (http://www.fit-
outco mes.com). At the start of each session, the child and 
the parents (if attending the session) completed the Dutch 
translation of the Outcome Rating Scale (ORS) about the 
child on an iPad by putting a mark on a visual ten-centimeter 
scale, ranging from ‘very bad’ on the left side to ‘very good’ 
on the right side. The ORS consists of four items about the 
well-being of the child [at (1) individual level, (2) family 
level (3) social level, (4) general level]. Completing the 
ORS took 2 minutes. The Total ORS score (range 0–40) 
was immediately shown in a graph, which reflected the pro-
gress of the patient over the treatment period. This progress 
was set against two reference lines that indicated the average 
course of successful and non-successful treatment outcomes 
822 European Child & Adolescent Psychiatry (2019) 28:819–834
1 3
respectively, given the initial patient ORS score based on an 
extensive database. Similarly, at the end of each session, the 
child and the parents (if attending the session) completed 
the Dutch translation of the Session Rating Scale (SRS) for 
themselves, which also contains four items about the way 
they perceived the session [(1) relationship (2) goals and 
setting, (3) approach and methods, (4) overall]. While the 
ORS was completed for the child in all cases, the SRS was 
filled in for the session participant, which could be the child 
or the parents. The Total SRS score (range 0–40) was shown 
in the same graph and reflected the curve of the way the 
patient was experiencing treatment. The SRS curve was also 
set against a cut-off line based on the same large dataset. 
The therapist and the patient were encouraged to discuss 
the results shown in the graph. This conversation is the main 
point of FIT and creates added value.
The FIT approach meets the criteria for Evidence-Based 
Practice of the American Psychological Association [33] 
Analysed (n=80) 
Care as Usual (n=80) 
Assessed for eligibility (n=525) 
Included (285) 
Excluded (n=240) 
Declined to participate (n=211) 
No intake (n=16)
No digital questionnaire possible 
(n=11) 
Older than 18 years (n=2) 
Allocation 
Enrollment 
Randomized (n=285) 
Received allocated intervention (n=136) 
Did not receive allocated intervention (n=38) 
Therapist did not receive FIT training (n=12) 
No treatment after intake (n=26) 
Received allocated care as usual (n=90) 
Did not receive care as usual (n=21) 
No treatment after intake (n=21) 
Follow-Up 
Complete follow-up (n=80) 
Lost to follow-up (n=10) 
Only one follow-up measure (n=10) 
Complete follow-up (n=86) 
Lost to follow-up (n=50) 
Only one or two FIT sessions (n=45) 
Only one follow-up measure (n=5) 
Analysis 
Analysed (n=86) 
3-8 sessions FIT (n=41) 
9+ sessions FIT (n=45) 
Fig. 1  Flowchart of this study
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as recognized by the Substance Abuse and Mental Health 
Services Administration (see also Tilsen [34]). Research has 
shown that the translated Dutch ORS and SRS have suffi-
cient reliability and a limited validity for the Dutch popula-
tion [35, 36]. Janse et al. concluded that the Dutch ORS and 
SRS were suitable questionnaires for following progress dur-
ing treatment, but recommended the use of a second ques-
tionnaire for measuring treatment outcome [36]. So far, only 
one study has reported the psychometric properties of the 
ORS for children. This demonstrated that the instrument had 
sufficient validity and good reliability [37].
The care provided in the experimental group as well as 
in the control group was in accordance with the same clini-
cal protocols. The vast majority of children received child 
psycho-education (generally once a week, over a 10-week 
period). This was followed in some instances by a (social) 
skills training (weekly, over a period of 10 weeks), emo-
tion or behavior regulation skills training, Psycho-motoric 
Therapy (generally once a week, over a period of 15 weeks), 
(Cognitive) Behavioral Therapy during 15 weeks and phar-
macotherapy. Parents attended psycho-education and par-
ent mediation therapy ranging from low-frequency sessions 
with a psychologist (for example, once per month) to inten-
sive parental training set-up in their home environment (for 
example twice a week, for 25 weeks) by a family worker.
Measures
Behavioral problems at baseline were measured using par-
ents’ ratings on the Dutch translation of the Child Behavior 
Checklist (CBCL) at the start. This is a widely used stand-
ardized questionnaire for children aged 6–18 years [38]. The 
CBCL is a parents’ rating scale, which measures children’s 
general problem behavior and internalizing and external-
izing behavior, while more specific problem behaviors are 
assessed with supplementary scales. To compare the experi-
mental and control groups, we used the total scale, external-
izing behavior scale, internalizing behavior scale and the 
subscales [38]. Internal consistencies (Cronbach’s Alpha) 
for the Dutch version were found to be > 0.90 [39].
To reduce observer rating bias, we decided to use two 
outcome measures which (1) differ from the feedback meas-
ures collected by the therapist during the treatment (see also 
Shimokawa 2010 [6]) and (2) are also assessed by other peo-
ple (in this case the parents) than the therapists (see also 
Kendrick 2016 [23]).
Assessing the treatment outcome in terms of QoL, we 
used the Dutch translation of the Kidscreen 27 Question-
naire [40, 41]. The Kidscreen 27 has 27 items represent-
ing five dimensions: Physical Well-being, Psychological 
Well-being, Autonomy and Parents, Peers and Social 
Support, and School Environment. Completing the Kid-
screen 27 takes 10–15 min. The items are scored on a 
five-point Likert scale, with a range from one (never) to 
five (always). The item scores are summarized per dimen-
sion and transformed into a T-score and percentiles. The 
intern consistency of the dimensions ranges from above 
mean to good (Cronbach’s Alpha > 0.70) [42].
To assess treatment outcome in terms of change in 
symptom severity level, we used the Dutch translation of 
the Youth Outcome Questionnaire (Y-OQ30) [43–45]. The 
Y-OQ 30 has 30 items and can be completed in 10–15 min 
using a five-point Likert scale with a range from 0 (never) 
to 4 (always). The Y-OQ30 has six subscales: Somatic 
Complaints, Social Isolation, Aggression, Behavior Prob-
lems, Hyperactivity/Concentration Problems and Depres-
sion/Anxiety. The item scores per subscale are summa-
rized in a total score. The Y-OQ30 is a valid and reliable 
instrument for assessing change in functioning [45, 46]. 
The validity and reliability of the Dutch translation are 
currently being investigated (Baars, ongoing study).
Parents digitally completed the Kidscreen 27 and the 
Y-OQ30 about their child at the start of the treatment, 
every 3 months subsequently and finally at the end of 
treatment.
Sample size
Power analysis was conducted in G*Power. Running a power 
analysis on a repeated measures ANOVA with four meas-
urements, three groups, a power of 0.80, an alpha level of 
0.05, and a small effect size (f = 0.05) [47, 48], the required 
total sample size was 129 for an unclustered RCT (43 
patients per arm). To adjust for within-cluster correlation, 
we calculated the design effect or inflation factor (Design 
effect = 1+(m − 1)ρ, whereby m is the average cluster size 
and ρ is the intraclass correlation coefficient or ICC) [49, 
50]. Based on pilot data, in this study, the average cluster 
size was set at m = 20 and the ρ = 0.001. The design effect 
was, therefore, set at 1.03. The total sample size for the clus-
ter RCT was 132 patients.
Randomization
The randomization procedure was based on random num-
ber tables and was performed using a computer-generated 
sequence with allocation concealment. The random alloca-
tion of the location clusters was performed before patient 
recruitment and enrolment started. Accordingly, all par-
ticipating therapists associated with the same Autism Care 
Team and their patients were randomized into the same con-
dition. A total of eight clusters were randomized among the 
two conditions. The average cluster size was 20.75 with a 
standard deviation of 10.57.
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Statistical methods
Analyses were performed according to the intention-to-
treat (ITT) principle including every subject who had been 
randomized according to the randomized treatment assign-
ment. Demographic variables, diagnosis characteristics 
of the participating patients and treatment characteristics 
were summarized using descriptive statistics and compared 
between the experimental and control group to verify prog-
nostic comparability at baseline. Baseline characteristics 
are presented in mean (M) and Standard Deviation (SD) 
for continuous variables, or as frequencies and percentages 
for categorical variables. To check for possible differences 
between the three groups, we used an ANOVA for continu-
ous variables or X2 test for categorical variables.
As assessed by inspection of a boxplot, we identified three 
participants with outlier scores due to an unusually high 
(more than 3 SD), but not invalid score at one measurement 
point: three times for the total score of the Y-OQ30, two 
for the subscales Aggression, and Depression and Fear and 
one for the subscale Conduct Problems all of the Y-OQ30. 
Because these were valid scores, we decided to keep them in 
the analysis. To examine the effect of removing the outliers, 
we have re-run the analyses without outliers.
Scores for each group were normally distributed, as 
assessed using Shapiro–Wilk’s test (p > 0.05), and vari-
ances were homogeneous, as assessed using Levene’s test 
for equality of variances for all variables.
To estimate group differences in rates of change in QoL 
(Kidscreen-27) or rates of change in symptom severity 
level (Y-OQ30), we used mixed-effects linear models with 
repeated measures. These models allow using all available 
data of subjects with randomly missing data and take into 
account unequal intervals between assessments, as was the 
case between time points 4 and 5 and also the hierarchical 
structure and dependency in the data. The repeated measures 
are correlated within participants and are nested in the two 
groups (FIT or CAU). Although each group was nested in 
clusters of four (clinic) locations (as result of the cluster 
randomization), the ICC was small (Kidscreen-27 total score 
ICC = 0.0081; Y-OQ30 total score ICC = 0.0215); therefore, 
location was not a contextual variable affecting the outcome, 
and therefore was left out of our model. The predictors in the 
models were Time, Group and Time × Group. All models 
included fixed effects for Time and Group and the interac-
tion between Time and Group. The models also included a 
random effect of individual intercepts, taking into account 
the correlated data within individuals. The overall group 
comparison was followed by post hoc pairwise compari-
son. Correction for multiple comparisons was applied to 
the overall analyses using the False Discovery Rate (FDR) 
with an FDR adjusted p value setting of 0.05 [51]. For these 
analyses, Statistical Package for the Social Sciences (SPSS) 
for Windows, Version 22.0 (SPSS Inc., Chicago, Ill, USA) 
software was used.
Results
Baseline characteristics
Table 1 shows the baseline demographic and clinical char-
acteristics of the participants. Overall, no group differences 
were found for age (mean CAU 10.2, SD ± 3.0; FIT 3–8 11.1, 
SD ± 2.9; FIT 9 + 10.9, SD ± 3.2; p = 0.28), gender (CAU 
75.0% male; FIT 3–8 73.2% male; FIT 9 + 68.9%; p = 0.76) 
and diagnosis (CAU 78.8% ASD, 15.0% Attention-Deficit 
Hyperactivity Disorder (ADHD), 6.3% other; FIT 3–8 87.5% 
ASD, 9.8% ADHD, 2.4% other; FIT 9 + 86.6% ASD 0.0% 
ADHD, 13.3% other; p = 0.10). In the FIT 9 + group, Cog-
nitive Behavioral Therapy (p < 0.001) was more frequently 
offered, in the CAU more Psycho-Education (p = 0.03) and 
in the FIT 3–8 slightly more Expressive/Psychomotoric 
Therapy (p = 0.43).
We ran an ANOVA to determine if there were differ-
ences at baseline for the total scores on the CBCL 6–18, 
the Kidscreen 27 and the Y-OQ30 between the CAU and 
FIT groups. Table 1 shows there was no significant differ-
ence on the CBCL total score between the CAU (M = 69.0, 
SD = 23.7), FIT 3–8 (M = 66.0, SD = 30.3) and the FIT 
9 + (M = 68.0, SD = 25.3) (p = 0.85). However, we did find 
a significantly higher score on the subscale Withdrawn/
Depressed in the FIT 3–8 (p = 0.02). There was no sig-
nificant difference between the baseline total scores on the 
Kidscreen 27 between the CAU (M = 95.6, SD= 12.6), the 
FIT 3–8 (M = 91.8, SD= 12.6) and the FIT 9 + (M = 93.0, 
SD= 11.0) (p = 0.23). There was a significantly higher score 
on the subscale Psychological Well-being for the CAU 
(p = 0.04). Furthermore, no significant difference was found 
between the baseline total scores on the Y-OQ30 between 
the CAU (M = 38.8, SD= 15.4), the FIT 3–8 group (M = 40.8, 
SD= 19.5) and the FIT 9 + group (M = 41.0, SD= 15.9) 
(p = 0.75). For the subscale Depression and Fear, there was 
a significantly higher score for the FIT 3–8 (p = 0.57). After 
removing the outliers from the analyses, there were no sig-
nificant differences for this subscale.
Effect of treatment: primary outcome QoL
As shown in Table 2 and Fig. 2, we conducted linear mixed 
modeling to examine Time by Group interactions for the 
primary and secondary outcome measures. For the QoL 
total score, we found a significant effect for Time [F (4, 
465) = 7.92, p < 0.00] and for Group [F (2, 165) = 3.16, 
p = 0.045], but no interaction effect was found [F (8, 
465) = 0.96 p = 0.47]. Treatment over time had a positive 
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Table 1  Baseline demographic 
and clinical characteristics of 
the participants
Care as usual 
(n = 80)
FIT 3–8 ses-
sions (n = 41)
FIT 9 + ses-
sions (n = 45)
p value
Age (year), (mean, ± SD) 10.2 ± 3.0 11.1 ± 2.9 10.9 ± 3.2 0.277
Gender, n (%)
 Male 60 75.0% 30 73.2% 31 68.9% 0.761
 Female 20 25.0% 11 26.8% 14 31.1%
Diagnosis, n (%)
 Attention-deficit hyperactivity disorder 12 15.0% 4 9.8% 0 0.0% 0.103
 Autistic disorder 20 25.0% 11 26.8% 10 22.2%
 Pervasive developmental disorder-NOS 34 42.5% 21 51.2% 20 44.4%
 Asperger syndrome 9 11.3% 4 9.8% 9 20.0%
 Other 5 6.3% 1 2.4% 6 13.3%
Therapy received
 Cognitive behavioral therapy, n (%) 24 24.7% 18 18.6% 35 36.1% 0.000
 Pharmaceutical therapy, n (%) 48 40.0% 20 16.7% 23 19.2% 0.423
 Family and system therapy, n (%) 36 45.6% 16 20.3% 13 16.5% 0.208
 Parental guidance, n (%) 46 33.3% 28 20.3% 30 21.7% 0.412
 Psycho-education, n (%) 45 35.4% 27 21.3% 36 28.3% 0.028
 Psychotherapy, n (%) 76 37.3% 40 19.6% 44 21.6% 0.653
 Supportive treatment patient, n (%) 20 52.6% 9 23.7% 4 10.5% 0.089
 Skills training, n (%) 9 27.3% 5 15.2% 10 30.3% 0.220
 Expressive/psycho-motoric therapy, n (%) 4 13.3% 8 26.7% 6 20.0% 0.043
CBCL 6-18 baseline
 Anxious/depressed, (mean, ± SD) 8.4 ± 5.3 7.8 ± 5.2 9.2 ± 5.3 0.465
 Withdrawn/depressed, (mean, ± SD) 5.7 ± 3.3 7.7 ± 3.8 6.4 ± 3.5 0.021
 Somatic complaints, (mean, ± SD) 3.8 ± 3.3 4.0 ± 4.1 5.4 ± 4.3 0.087
 Social problems, (mean, ± SD) 7.2 ± 3.5 6.6 ± 3.6 7.5 ± 4.0 0.581
 Thought problems, (mean, ± SD) 7.1 ± 3.9 6.5 ± 4.1 7.0 ± 4.0 0.752
 Attention problems, (mean, ± SD) 10.8 ± 3.9 9.6 ± 3.9 9.6 ± 3.7 0.134
 Rule-breaking behavior, (mean, ± SD) 4.8 ± 3.3 4.4 ± 4.1 3.6 ± 2.8 0.188
 Aggressive behavior, (mean, ± SD) 14.1 ± 7.4 13.5 ± 8.3 12.9 ± 7.4 0.724
 Internalizing behavior, (mean, ± SD) 17.9 ± 9.3 19.4 ± 11.5 21.0 ± 10.7 0.304
 Externalizing behavior, (mean, ± SD) 18.9 ± 9.7 17.9 ± 11.8 16.4 ± 9.4 0.486
 Total score, (mean, ± SD) 69.0 ± 23.7 66.0 ± 30.3 68.0 ± 25.3 0.845
KIDSCREEN-27 baseline
 Autonomy and parent relation 26.6 ± 3.7 27.5 ± 3.6 26.9 ± 3.6 0.489
 Peers and social support 13.2 ± 3.4 13.0 ± 3.2 13.2 ± 3.3 0.954
 School environment 13.9 ± 3.0 12.7 ± 3.2 14.0 ± 2.7 0.062
 Physical well-being 16.9 ± 3.7 15.5 ± 3.6 15.7 ± 3.9 0.099
 Psychological well-being 25.0 ± 4.3 23.1 ± 5.0 23.3 ± 4,2 0.036
 Total score 95.6 ± 12.6 91.8 ± 12.6 93.0 ± 11.0 0.226
Y-OQ-30 baseline
 Somatic complaints 3.7 ± 2.6 3.8 ± 3.3 4.4 ± 2.9 0.459
 Social isolation 2.6 ± 2.0 3.4 ± 2.5 3.2 ± 2.2 0.189
 Aggression 2.2 ± 2.6 2.5 ± 3.0 2.4 ± 2.3 0.858
 Behavioral problems 7.4 ± 4.9 7.0 ± 5.4 6.5 ± 4.4 0.633
 Hyperactivity and concentration problems 7.4 ± 2.6 6.8 ± 2.9 6.8 ± 3.1 0.484
 Depression and fear 6.2 ± 3.6 8.0 ± 5.2 8.0 ± 4.6 0.057
 Total score 38.8 ± 15.4 40.8 ± 19.5 41.0 ± 15.9 0.752
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influence on improvement in QoL, as well as adding FIT 
to treatment. The effects of Time and Group did not rein-
force each other. Post hoc pairwise comparisons showed 
that this difference for Group was seen between the FIT 
3–8 and CAU.
A positive and significant effect was found for Group 
on the subscale School Environment [F (2,163) = 3.93, 
p = 0.02] and Physical Well-being [F (2,166) = 4.00, 
p = 0.02]. Post hoc pairwise comparison showed that this 
difference was between CAU and 3–8 FIT. However, no 
interaction effect was found for both the subscale Physical 
Well-being and School Environment.
Significant positive effects for Time on subscale 
level were found for Autonomy and Parent Relation 
[F (4,462) = 5.2 p < 0.00], School Environment [F 
(4,476) = 2.39 p =0.05] and Psychological Well-being [F 
(4,465) = 10.74 p < 0.00].
Effect of treatment: secondary outcome Symptom 
Severity
For the Symptom Severity outcome (Y-OQ30), as shown 
in Table 3 and Fig. 3, we found a significant effect for 
Time [F (4, 409) = 23.89, p < 0.001], but not for Group 
[F (2, 158) = 0.19, p = 0.83] and there was no interaction 
effect for Time by Group [F (8, 409) = 1.72, p = 0.09]. All 
participants profit from treatment, but the addition of FIT 
did not create a significant difference between the groups 
in symptom severity reduction.
We did find an interaction effect for symptom sever-
ity reduction for the subscale Depression and Fear [F (8, 
413) = 1.93 p = 0.05]. However, this difference may have 
been caused by a higher baseline score for participants in 
both FIT groups. This was also shown in Table 1, where 
we found significantly higher scores on the CBCL and 
the Y-OQ30 on subscales for Depression at baseline for 
both FIT groups. Additionally, an interaction effect for the 
subscale Hyperactivity and Concentrations Problems was 
found [F (8, 416) = 1.97, p = 0.05] suggesting that the two 
groups which received FIT showed a significantly higher 
decrease compared with the control group.
We found significant positive effects for Group for 
the subscale Depression and Fear [F (2, 160) = 3.55 
p = 0.03]. Furthermore, we found positive effects for Time 
for all subscales: Somatic Complaints [F (4, 413) = 6.55 
p < 0.001], Social Isolation [F (4, 413) = 5.17 p < 0.001], 
Aggression [F (4, 412) = 8.47 p < 0.001], Behavior Prob-
lems [F (4, 410) = 12.99, p < 0.001], Hyperactivity and 
Concentration Problems [F (4, 415) = 18.03, p < 0.001], 
Depression and Fear [F (4, 413) = 11.5, p < 0.001].
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Sensitivity analysis
To test the robustness of the findings, we performed sev-
eral separate analyses. First, we looked at the results after 
removing the outliers. We found a significant interaction 
effect for Time by Group [F (8, 402) = 2.10 p = 0.035] for 
the total scale of the Y-OQ30. The estimated means show 
that this effect applies particularly to the FIT 9 + . We 
also found a significant interaction effect on the subscale 
Depression and Fear [F (8, 407) = 2.23, p = 0.024] and a 
significant interaction effect for the subscale Hyperactivity 
and Concentration problems [F (8, 409) = 1.99, p = 0.05].
Secondly, we examined the effect of Time by Sever-
ity interactions for the KIDSCREEN-27 total score and 
the Y-OQ30 total score. To define Severity, we used the 
clinical cut-off scores of the CBCL at baseline (normal, 
borderline and clinical). As for the KIDSCREEN-27, we 
found a significant effect for Severity [F (2, 147) = 7.908, 
p = 0.001]. The estimated marginal means of the KID-
SCREEN-27 for children with clinical, borderline and 
normal scores were 94.2, 100.0 and 102.1, respectively. 
Post hoc pairwise comparisons showed that this difference 
in QoL was seen in children with a score in the normal 
range versus children with clinical scores. No interaction 
effect was found for Severity by Time [F (8, 422) = 1.525 
p = 0.147].
Examining the Y-OQ30, a significant effect for Sever-
ity [F (2, 143) = 23.6, p < 0.000] was found. The estimated 
marginal means of the Y-OQ30 for clinical, borderline and 
normal scores were 40.2, 25.9 and 22.4, respectively. No 
interaction effect was found for Severity by Time [F (8, 
374) = 0.452 p = 0.889]. These results suggest that independ-
ent of Severity, all groups showed a decrease in symptom 
severity outcome over Time, but the decreases in scores were 
equal in all three groups.
Furthermore, we performed a subgroup analysis, select-
ing children who scored clinically on the CBCL at baseline. 
No significant Time × Group interactions were seen for both 
outcome variables.
To test the robustness of the findings with respect to 
similarities within the clusters, we also performed a sensi-
tivity analysis, considering the clusters. For the outcomes, 
we defined the following levels: the repeated observations 
(level 1) nested within Group (level 2) nested within Loca-
tion (level 3). No interaction effect was found for the KID-
SCREEN-27 total score [F (47, 475) = 1.028, p < 0.426], nor 
for the Y-OQ30 total score [F (55, 404) = 1.231, p < 0.136].
Discussion
The purpose of this study was to investigate the efficacy 
of adding FIT to CAU in a child and adolescent psychiatry 
setting. The main finding of this study is that the systematic 
use of patients’ feedback in treatment leads to a more pro-
nounced increase of QoL. Although adding FIT to treatment 
is effective in gaining a more significant increase in QoL, no 
additional effects were seen in decreasing symptom severity. 
Interestingly, no interaction with the duration of treatment 
was found.
The positive effect of FIT on QoL is certainly interesting 
because in previous feedback studies treatment outcome has 
rarely been measured in terms of QoL [23]. This is remark-
able because both QoL and patients’ feedback emphasize the 
patients’ view of their situation. It has been stated that QoL 
is the subjective perception and evaluation by the patient of 
their situation [27]. In our study, the QoL of the children 
was reported by the parents and therefore can be viewed as 
a measurement of the abilities and functioning of the child 
by the parent [27, 52]. We hypothesize that the parents’ con-
ceptualization of the child’s abilities depends on their level 
of distress based on their judgement of the severity of the 
ASD. Their distress also depends on the extent to which oth-
ers, like therapists, meet their needs. In FIT, the emphasis is 
Fig. 2  Estimated marginal 
means of the total score on the 
Kidscreen-27 at T1, T2, T3, T4 
and T5
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on therapists fostering supportive interactions with parents 
and the child and monitoring if they are meeting their needs. 
Positively influencing patients’ expectations, as is incorpo-
rated in FIT, is known as an important factor in treatment 
[8]. By doing so, therapists using FIT can enhance a positive 
view of the child’s QoL as seen through the eyes of the par-
ent. The effect of FIT on patients’ expectations is an inter-
esting topic for further research. It could be speculated that 
only the patients can report the QoL as a subjective concept 
(e.g., the child or adolescent) [27, 52]. Conceptualized in 
this way, it would be very interesting to study QoL measures 
between the child or adolescent, and their parents [27].
Adding FIT had no significant effect on decreasing 
symptom severity, although, based on the literature, we had 
expected a positive effect [1–4]. Our findings, however, are 
in line with the meta-review of the Cochrane Collaboration 
[23]. It is important to note that, to the best of our knowl-
edge, no feedback study has been reported with children 
with ASD. It could be considered that the symptom severity 
for children with ASD is thought to be a ‘life-long’ condi-
tion, which is partially supported by data on adults with 
autism [53], at least with respect to symptom distributions 
in different age cohorts. At the same time, we found a sig-
nificant decrease in symptom severity in our ASD sample 
over time, although this should be carefully interpreted since 
we did not specifically measure the core symptoms of ASD. 
Current research on the stability of ASD symptom severity 
over time has concluded that changes do indeed occur in 
developmental trajectories of ASD, in both directions [54, 
55]. Earlier research on moderating factors suggests that the 
positive effects of using feedback are stronger for patients 
who are at risk of treatment failure or who deteriorate during 
treatment (known as ‘patients not on track (NOT) to reach 
their goal for therapy’) [1, 3–6]. In our sample, we were 
unable to study the effects of such moderating factors, partly 
because yet there are no reliable Dutch norms for the ORS 
to define when a patient is not on track.
In this study, FIT was added to care as usual. The thera-
pists using FIT were asked to discuss the feedback outcome 
as shown in the graph during treatment. We did not measure 
whether the feedback was used to tailor the general treatment 
plan as prescribed in the care as usual, nor in what way the 
therapists changed their attitude or behavior. It is suggested 
that a more deliberate practice by the therapist, based on 
feedback is a moderator for a positive effect of feedback 
on treatment outcome [56, 57]. The effect of feedback on 
outcome may also be moderated by therapist characteris-
tics, in particular, their attitude and openness to the patient’s 
feedback [18, 19]. In our study, we were not able to ana-
lyze the data regarding this issue. In addition, these factors 
might imply a moderating role of the organizational aspects, 
social context, etc. [12, 13]. It is beyond the scope of this 
current study to take all these into account, but it is highly Re
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recommended for further research to sort out the effects of 
such moderators systematically.
We suspect that specific child characteristics may also 
moderate the effect of feedback. Duncan et al. concluded that 
the child’s self-reported ORS is positively correlated with 
the caregiver’s view and is, therefore, a reliable and valid 
marker of treatment progress [37]. Our sample was a group 
with ASD. We chose this group because it is the largest 
patient group in our treatment center (Karakter). Therapists 
in this study mentioned that some children had difficulties 
in completing the ORS or SRS in a sensible way. The FIT 
supervisor emphasized the value of talking about how the 
children experience the treatment even if these children had 
difficulties in completing the questionnaires. It is possible 
that FIT does not function optimally under these conditions. 
We recommend extending this research to other child psy-
chiatric samples with severe problems, including ADHD, 
Depression or Anxiety disorders, Behavioral problems or 
Personality disorders.
This study showed a significant increase in QoL and a 
significant decrease in symptom severity by following treat-
ment over a certain period of time, which positively under-
scores the importance of treatment availability for children. 
The effect of FIT on QoL was found for the group with 3–8 
FIT sessions. Although we expected a positive relationship 
between the frequency of feedback and outcome [4, 31], we 
did not find it in our study. The different effect between the 
two FIT groups cannot be explained by differences in room 
for improvement depending on symptom severity, since the 
groups did not differ in severity at baseline and, in addition, 
we found no interaction effect for severity. As mentioned 
before, we did not find a robust interaction effect between 
Time and adding FIT. We expected a stronger effect for FIT, 
mainly in the first episode. This would be in line with previ-
ous findings about trajectories of change, with most change 
occurring earlier rather than later in the treatment process 
indicating, the importance of the critical initial phase (see 
Miller et al. [58] and also Amble et al. [59] for an over-
view). Our finding suggests we should reconsider the Time 
factor. Changes in treatment do not occur in a linear way 
but appear with sudden gains and sudden losses at different 
time moments. A broader and very intriguing reflection on 
this finding is found by Schiepek et al. [60, 61]. Based on 
Synergetic theories, they examined treatment as a complex, 
dynamic, non-linear process of change. They emphasize the 
importance of the use of patients’ feedback in creating sen-
sitivity within the therapist and the patient for critical stages 
in treatment as a change process [62]. We are extending our 
theoretical feedback model for further research to take this 
into account [63].
Limitations
The results of this study should be interpreted in the con-
text of certain limitations. Although we are convinced of 
the importance of performing treatment effect research 
in a realistic clinical environment, we had to accept some 
practical limitations. Due to organizational context factors, 
such as a considerable time delay between the diagnostics 
phase and the treatment phase, we extended the inclusion by 
6 months and then terminated for budgetary reasons. During 
the inclusion and treatment phase, several therapists changed 
teams due to organizational reorganization. Although these 
changes did not influence the comparability of the therapist 
groups, we had to make a stronger effort to keep adherence 
to the protocol. Due to organizational and administrative 
reasons, we were limited in calculating the ratio between the 
number of FIT sessions and the total number of treatment 
sessions. Interestingly, we noticed that most of the therapists 
showed enthusiasm for using FIT as an important commu-
nication tool with patients. Most of the FIT teams decided 
to continue using FIT after the study ended.
Earlier, we mentioned a limitation of not being able 
to define and administer when a patient is NOT. It is 
Fig. 3  Estimated marginal 
means of the total score on the 
Y-OQ-30 at T1, T2, T3, T4 
and T5
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recommended to develop norms to be able to adequately 
define and assess NOT for further research.
Another limitation was the relatively small sample size as 
indicated by the rather strong effect of the outlier scores. Our 
second analysis, without the outlier scores for the Y-OQ30, 
showed a significant interaction effect for Time and Group 
on symptom severity, where keeping the outlier scores in 
the analysis decreases the significance to non-significant. 
A larger sample size would have minimized the effect of a 
possible outlier.
We hypothesize another possible limitation: we could not 
control for a conceivably natural tendency of therapists in 
the control group to be attentive to what is important for the 
patient. The effect of the systematic use of feedback in the 
FIT group on treatment outcome in comparison with the 
CAU group could be somewhat weakened by these natural 
phenomena in the CAU group which fits in the democratiz-
ing process of healthcare.
Conclusion
In conclusion, the systematic use of FIT in a Child and 
Adolescent Psychiatric setting may increase QoL but does 
not seem to result in a more pronounced decrease in symp-
tom severity compared with CAU. It is suggested that FIT 
changes the expectations of parents in a positive way. These 
results should be replicated in other samples and include 
an extensive study on the moderating factors that may be 
involved.
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